Kathryn Hitchcock
Papers
3
Total Citations
111
H-Index
3
About
Dr. Kathryn Hitchcock is a leading radiation oncologist whose research centers on optimizing treatment for oropharyngeal cancer, particularly through the integration of transoral robotic surgery (TORS) and personalized adjuvant therapy. Her major contributions include defining patient selection criteria for TORS, demonstrating that clear surgical margins and the absence of extra-nodal extension can safely de-escalate adjuvant treatment—thereby reducing long-term toxicity without compromising outcomes. Her work has directly challenged historical protocols that defaulted to definitive radiation or invasive open procedures, offering patients a less morbid path. With her most-cited paper (71 citations) establishing TORS as a viable primary modality, and subsequent studies (27 and 13 citations) refining the roles of margins and adjuvant therapy, Dr. Hitchcock has shaped national practice. Notably, she has highlighted gaps between standard guidelines and real-world adjuvant treatment use, advocating for evidence-based, individualized care. Her research empowers clinicians to move beyond one-size-fits-all approaches, improving both survival and quality of life for patients with HPV/p16-positive oropharyngeal cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3